Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: An updated meta-analysis

Lung

Volumn 192, Issue 5, 2014, Pages 739-748

  Lao, Xianjun ^a   Qin, Xue ^a   Peng, Qiliu ^a   Chen, Zhiping ^b   Lu, Yu ^a   Liu, Yanqiong ^a   Li, Shan ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

CYP1B1; Lung cancer; Meta analysis; Polymorphism

Indexed keywords

CYTOCHROME P450 1B1; CYP1B1 PROTEIN, HUMAN;

AFRICAN AMERICAN; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; LUNG CANCER; META ANALYSIS; PUBLISHING; SENSITIVITY ANALYSIS; SMOKING; ADVERSE EFFECTS; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MALE; PHENOTYPE; RISK; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CYTOCHROME P-450 CYP1B1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84907592888     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-014-9618-1     Document Type: Article

References (39)

1. Evans M (2013) Lung cancer: needs assessment, treatment and therapies. Br J Nurs 22:S15-16, S18, S20-12
2. Janssen-Heijnen ML, Coebergh JW (2003) The changing epidemiology of lung cancer in Europe. Lung Cancer 41:245-258
3. Thielen A, Klus H, Muller L (2008) Tobacco smoke: unraveling a controversial subject. Exp Toxicol Pathol 60:141-156
4. Yu D, Berlin JA, Penning TM, Field J (2002) Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53. Chem Res Toxicol 15:832-842
5. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomark Prev 12:689-698
6. Ragin CC, Langevin S, Rubin S, Taioli E (2010) Review of studies on metabolic genes and cancer in populations of African descent. Genet Med 12:12-18
7. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD et al (1997) Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57:3026-3031
8. Li DN, Seidel A, Pritchard MP, Wolf CR, Friedberg T (2000) Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol. Pharmacogenetics 10:343-353
9. Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ et al (2000) Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomark Prev 9:147-150
10. Sasaki M, Tanaka Y, Okino ST, Nomoto M, Yonezawa S, Nakagawa M et al (2004) Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer. Clin Cancer Res 10:2015-2019
11. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R (2003) CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res 63:3913-3918
12. Tang YM, Green BL, Chen GF, Thompson PA, Lang NP, Shinde A et al (2000) Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls. Pharmacogenetics 10:761-766
13. Ko Y, Abel J, Harth V, Brode P, Antony C, Donat S et al (2001) Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res 61:4398-4404
14. Timofeeva MN, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T et al (2009) CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences. Carcinogenesis 30:1161-1169
15. Cote ML, Yoo W, Wenzlaff AS, Prysak GM, Santer SK, Claeys GB et al (2009) Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis 30:626-635
16. Church TR, Haznadar M, Geisser MS, Anderson KE, Caporaso NE, Le C et al (2010) Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk. Int J Mol Epidemiol Genet 1:295-309
17. Schneider J, Bernges U (2009) CYP1A1 and CYP1B1 polymorphisms as modifying factors in patients with pneumoconiosis and occupationally related tumours: a pilot study. Mol Med Rep 2:1023-1028
18. Yoon KA, Kim JH, Gil HJ, Hwang H, Hwangbo B, Lee JS (2008) CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women. Lung Cancer 60:40-46
19. Shah PP, Singh AP, Singh M, Mathur N, Mishra BN, Pant MC et al (2008) Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer. Mutat Res 643:4-10
20. Sorensen M, Autrup H, Tjonneland A, Overvad K, Raaschou-Nielsen O (2005) Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer Lett 221:185-190
21. Liang G, Pu Y, Yin L (2005) Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population. Cancer Lett 223:265-274
22. Watanabe J, Shimada T, Gillam EM, Ikuta T, Suemasu K, Higashi Y et al (2000) Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10:25-33
23. Xu WH, Zhou YH, Hang XS, Shen D (2012) Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis. Mol Biol Rep 39:2821-2829
24. Chen B, Qiu LX, Li Y, Xu W, Wang XL, Zhao WH et al (2010) The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501 subjects. Lung Cancer 70:247-252
25. Cote ML, Wenzlaff AS, Bock CH, Land SJ, Santer SK, Schwartz DR et al (2007) Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Lung Cancer 55:255-262
26. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR et al (2005) CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 26:2207-2212
27. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558
28. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
29. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
30. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
31. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB et al (2008) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 29:1164-1169
32. Liang G, Pu Y, Yin L (2005) Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population. Cancer Lett 223:265-274
33. Roos PH, Bolt HM (2005) Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. Expert Opin Drug Metab Toxicol 1:187-202
34. Ada AO, S CK, Hancer F, Bilgen S, Suzen SH, Alpar S, et al. (2010) CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients. Neoplasma 57:512-521
35. Rotunno M, Yu K, Lubin JH, Consonni D, Pesatori AC, Goldstein AM et al (2009) Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PLoS One 4:e5652
36. Wu MF, Wu WJ, Chang GC, Chen CY, Hu SW, Tsai WT et al (2004) Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients. Toxicol Lett 150:211-219
37. Schoket B, Papp G, Levay K, Mrackova G, Kadlubar FF, Vincze I (2001) Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure. Mutat Res 482:57-69
38. Patel JD (2005) Lung cancer in women. J Clin Oncol 23:3212-3218
39. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF (2000) Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60:3440-3444